about
Monitoring therapeutic monoclonal antibodies in brain tumor.Sorafenib in breast cancer treatment: A systematic review and overview of clinical trialsRap2B promotes angiogenesis via PI3K/AKT/VEGF signaling pathway in human renal cell carcinoma.Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target.Sodium butyrate enhances the growth inhibitory effect of sunitinib in human renal cell carcinoma cells
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging antiangiogenics for renal cancer.
@en
type
label
Emerging antiangiogenics for renal cancer.
@en
prefLabel
Emerging antiangiogenics for renal cancer.
@en
P2093
P2860
P1476
Emerging antiangiogenics for renal cancer
@en
P2093
Amandine Quivy
Charlotte Domblides
Marine Gross-Goupil
P2860
P304
P356
10.1517/14728214.2013.858697
P407
P50
P577
2013-12-01T00:00:00Z